About N-(2-cyclobutylpyrazol-3-yl)-6-methyl-3,4-dihydro-2H-chromene-2-carboxamide
N-(2-cyclobutylpyrazol-3-yl)-6-methyl-3,4-dihydro-2H-chromene-2-carboxamide (PubChem CID 136567760) has the molecular formula C18H21N3O2
and a molecular weight of 311.38 g/mol. Its IUPAC name is N-(2-cyclobutylpyrazol-3-yl)-6-methyl-3,4-dihydro-2H-chromene-2-carboxamide.
Analyze N-(2-cyclobutylpyrazol-3-yl)-6-methyl-3,4-dihydro-2H-chromene-2-carboxamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-(2-cyclobutylpyrazol-3-yl)-6-methyl-3,4-dihydro-2H-chromene-2-carboxamide?
The IUPAC name of N-(2-cyclobutylpyrazol-3-yl)-6-methyl-3,4-dihydro-2H-chromene-2-carboxamide (CID 136567760) is N-(2-cyclobutylpyrazol-3-yl)-6-methyl-3,4-dihydro-2H-chromene-2-carboxamide.
What is the SMILES notation for N-(2-cyclobutylpyrazol-3-yl)-6-methyl-3,4-dihydro-2H-chromene-2-carboxamide?
The canonical SMILES for N-(2-cyclobutylpyrazol-3-yl)-6-methyl-3,4-dihydro-2H-chromene-2-carboxamide is Cc1ccc2c(c1)CCC(C(=O)Nc1ccnn1C1CCC1)O2.
What is the InChIKey of N-(2-cyclobutylpyrazol-3-yl)-6-methyl-3,4-dihydro-2H-chromene-2-carboxamide?
The InChIKey is NYVGPEUXAGCIIZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H21N3O2/c1-12-5-7-15-13(11-12)6-8-16(23-15)18(22)20-17-9-10-19-21(17)14-3-2-4-14/h5,7,9-11,14,16H,2-4,6,8H2,1H3,(H,20,22).
What are the key properties of N-(2-cyclobutylpyrazol-3-yl)-6-methyl-3,4-dihydro-2H-chromene-2-carboxamide?
N-(2-cyclobutylpyrazol-3-yl)-6-methyl-3,4-dihydro-2H-chromene-2-carboxamide has a molecular weight of 311.38 g/mol, XLogP of 3.25, 3 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for N-(2-cyclobutylpyrazol-3-yl)-6-methyl-3,4-dihydro-2H-chromene-2-carboxamide is sourced from PubChem (CID 136567760), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).